Navigation Links
Regal One Announces Dividend of Rampart Detection Systems Common Stock
Date:5/31/2011

SCOTTSDALE, Ariz., May 31, 2011 /PRNewswire/ -- Regal One Corporation (OTCBB:RONE), an emerging business development corporation that is 100% focused on incubating and bringing public high quality companies, today announced it will distribute a special dividend of 300,000 shares of Rampart Detection Systems Ltd Common stock. Regal One is assisting in the filing of an F-1 registration statement with the United States Securities and Exchange Commission, wherein these shares may be registered in whole or in part for public resale. Based in Western Canada, Rampart is a world leader in applying the most advanced knowledge of electromagnetics and electrodynamics to detection and protection systems for police; defense; security; counter terrorism; emergency response and industry.

Regal shareholders of record June 10, 2011, will receive as a dividend, on pro rata basis, a total of 300,000 Rampart common shares. Rampart expects to file an F-1 registration statement on or about June 3, 2011. The dividend will be distributed to Regal shareholders after the registration statement is declared effective.

Since 2005 Regal One has been operating as a Business Development Corporation 100% focused on recruiting, coaching, and bringing public next-generation companies. Regal seeks high tech industrial and biomedical companies with well defined near-term applications that address significant and quantifiable markets. Based in Scottsdale, AZ, the company provides qualified candidates access to the best-of-breed advisors, and the shortest, least expensive path to public liquidity.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expects" and similar expressions identify such forward-looking statements. Although expected, actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of Regal One Corporation and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting Regal One and its operations; its markets, products, and portfolio performance, and other factors detailed in reports filed by Regal One with the SEC.


'/>"/>
SOURCE Regal One Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regal Introduces Four, Six and Eight Port Filtered and Un-Filtered Right Angle BNC Connectors
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 /PRNewswire/ ... of genomic services and solutions with cutting edge next-generation ... has completed a USD $75 Million [515 Million RMB] ... CMB International Capital Management ( Shenzhen ) ... Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment Center ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):